Next Article in Journal
Prevalence and Risk Factors Associated with Potentially Inappropriate Prescribing According to STOPP-2 Criteria among Discharged Older Patients—An Observational Retrospective Study
Next Article in Special Issue
A VEGFB-Based Peptidomimetic Inhibits VEGFR2-Mediated PI3K/Akt/mTOR and PLCγ/ERK Signaling and Elicits Apoptotic, Antiangiogenic, and Antitumor Activities
Previous Article in Journal
Alkaloids as Natural NRF2 Inhibitors: Chemoprevention and Cytotoxic Action in Cancer
Previous Article in Special Issue
Aptamers Versus Vascular Endothelial Growth Factor (VEGF): A New Battle against Ovarian Cancer
 
 
Review

Article Versions Notes

Pharmaceuticals 2023, 16(6), 851; https://doi.org/10.3390/ph16060851
Action Date Notes Link
article xml file uploaded 7 June 2023 08:52 CEST Original file -
article xml uploaded. 7 June 2023 08:52 CEST Update https://www.mdpi.com/1424-8247/16/6/851/xml
article pdf uploaded. 7 June 2023 08:52 CEST Version of Record https://www.mdpi.com/1424-8247/16/6/851/pdf
article html file updated 7 June 2023 08:54 CEST Original file -
article html file updated 20 June 2023 21:03 CEST Update https://www.mdpi.com/1424-8247/16/6/851/html
Back to TopTop